Abstract
Purpose
To assess the status of EGFR, HER-2, and CCND1 at the gene and protein levels in esophageal squamous cell carcinoma.
Methods
Dual-color FISH assays were performed using DNA probes for EGFR/CEP 7, HER-2/CEP 17, and CCND1/CEP 11. The respective proteins, furthermore, was assessed in IHC assays and correlated with patient and tumor characteristics.
Results
From 55 ESCCs, 8 (15%) tumors showed gene amplification and 20 (36%) had gene overrepresentation (balanced gene and chromosome 7 polysomy) for EGFR. High-level protein expression was frequent (49%), positively correlated with gene copy numbers (kappa=0.4), and associated with well-differentiated histology (p=0.02). For HER-2, gene amplification was detected in a single tumor (2%) and protein overexpression was rare (9%). CCND1 gene was amplified in 23 (42%) tumors; likewise, CCND1 protein overexpression was common (58%) and prevailed in gene overrepresentation or amplification. Only 1 patient showed gene amplification for both EGFR and CCND1. Survival was not associated with EGFR or CCND1 gene/protein status, whereas negative patients for HER-2 protein had a better survival than positive patients (p=0.04).
Conclusions
Frequent overexpression and gene amplification of EGFR and CCND1 make these molecules and their pathways potential therapeutic targets for ESCC. In addition, EGFR and CCND1 appeared to be independently altered suggesting alternative mechanisms for pathway activation. Therapeutic agents targeting these molecules are urged to be tested in clinical trials and comprehensive biological analyses should be included to properly interpret the outcome.
Similar content being viewed by others
References
Adelaide J, Monges G, Derderian C, Seitz JF, Birnbaum D (1995) Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br J Cancer 71:64–68
Anonymous (2001) Prognostic significance of cyclin D1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases. J Am Coll Surg 192:708–718
Arteaga CL (2002) Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 7 (Suppl 4):31–39
Gotoh M, Kawabe S, Takiuchi K, Katsu I (2002) EGFR and cyclin D1 are possible predictors of sensitivity to chemoradiotherapy (CRT) for esophageal squamous cell carcinoma (SCC). Proc Am Soc Clin Oncol 21:164a
Gramlich TL, Fritsch CR, Maurer D, Eberle M, Gansler TS (1994) Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma. Diagn Mol Pathol 3:255–259
Hirsch FR, Varella-Garcia M, Franklin WA, Veve R, Chen L, Helfrich B, Zeng C, Baron A, Bunn PA Jr (2002) Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas. Br J Cancer 86:1449–1456
Hirsch FR, Varella-Garcia M, Maria MV di, Veve R, Baron AE, Zeng C, Bunn PAJr, Franklin WA (2003) Epidermal growth factor receptor in non-small cell lung carcinomas: correlation between gene and protein levels and impact on prognosis. J Clin Oncol
Ikeda Y, Ozawa S, Ando N, Kitagawa Y, Ueda M, Kitajima M (1996) Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas. Ann Thorac Surg 62:835–838
Itakura Y, Sasano H, Shiga C, Furukawa Y, Shiga K, Mori S, Nagura H. Epidermal growth factor receptor overexpression in esophageal carcinoma (1994) An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer 74:795–804
Kitagawa Y, Ueda M, Ando N, Ozawa S, Shimizu N, Kitajima M (1996) Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2:909–914
Mathew R, Arora S, Khanna R, Shukla NK, Mathur M, Ralhan R (2001) Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population. J Cancer Res Clin Oncol 127:251–257
Matsumoto M, Furihata M, Ohtsuki Y, Sasaguri S, Ogoshi S (2000) Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma. Anticancer Res 20:1947–1952
Nicholson RI, Gee JM, Harper ME (2001) EGFR and cancer prognosis. Eur J Cancer 37 (Suppl 4):S9–S15
Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds) (1997) Cancer incidence in five continents, vol 7. IARC Scientific Publications, Lyon, pp 1066–1071
Ross JS, McKenna BJ (2001) The HER-2/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest 19:554–568
Schrump DS, Nguyen DM (2001) The epidermal growth factor receptor-STAT pathway in esophageal cancer. Cancer J 7:108–111
Sheyn I, Noffsinger AE, Heffelfinger S, Davis B, Miller MA, Fenoglio-Preiser CM (1997) Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. Hum Pathol 28:270–276
Shiga K, Shiga C, Sasano H, Miyazaki S, Yamamoto T, Yamamoto M, Hayashi N, Nishihira T, Mori S (1993) Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression. Anticancer Res 13:1293–1301
Shimada Y, Imamura M, Watanabe G, Uchida S, Harada H, Makino T, Kano M (1999) Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology. Br J Cancer 80:1281–1288
Shinomiya T, Mori T, Ariyama Y, Sakabe T, Fukuda Y, Murakami Y, Nakamura Y, Inazawa J (1999) Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon. Genes Chromosomes Cancer 24:337–344
Slichenmyer WJ, Fry DW (2001) Anticancer therapy targeting the erbB family of receptor tyrosine kinases. Semin Oncol 28:67–79
Stocks SC, Pratt N, Sales M, Johnston DA, Thompson AM, Carey FA, Kernohan NM (2001) Chromosomal imbalances in gastric and esophageal adenocarcinoma: specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomas. Genes Chromosomes Cancer 32:50–58
Stokes ME, Davis CS, Koch GG (2000) Categorical data analysis using the SAS system, 2nd edn. SAS Institute, Cary, North Carolina
Suzuki H, Abo S, Kitamura M, Hashimoto M, Izumi K, Terada K, Sugiyama T (1997) Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables. Cancer Invest 15:411–415
Tada K, Oka M, Hayashi H, Tangoku A, Oga A, Sasaki K (2000) Cytogenetic analysis of esophageal squamous cell carcinoma cell lines by comparative genomic hybridization: relationship of cytogenetic aberrations to in vitro cell growth. Cancer Genet Cytogenet 117:108–112
Torzewski M, Sarbia M, Verreet P, Bittinger F, Dutkowski P, Heep H, Willers R, Gabbert HE (1997) The prognostic significance of epidermal growth factor receptor expression in squamous cell carcinomas of the oesophagus. Anticancer Res 17:3915–3919
Varis A, Puolakkainen P, Savolainen H, Kokkola A, Salo J, Nieminen O, Nordling S, Knuutila S (2001) DNA copy number profiling in esophageal Barrett adenocarcinoma: comparison with gastric adenocarcinoma and esophageal squamous cell carcinoma. Cancer Genet Cytogenet 127:53–58
Wang LS, Chow KC, Chi KH, Liu CC, Li WY, Chiu JH, Huang MH (1999) Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol 94:1933–1940
Acknowledgements. The authors acknowledge the skillful assistance of N. Aumen in the IHC assays, A. Palma in the database entry, and P. Taupradist for reviewing the patient data. This work was supported in part by the NCI grant CCSG P30-CA46934. P. Sunpaweravong and S. Sunpaweravong were post-doctoral fellows sponsored by the Prince of Songkla University, Songkla, Thailand.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sunpaweravong, P., Sunpaweravong, S., Puttawibul, P. et al. Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 131, 111–119 (2005). https://doi.org/10.1007/s00432-004-0610-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-004-0610-7